MicroRNA-33a and MiR-34a as a Molecular Targets for Pomegranate Peel Extract During Treatment of Non-Alcoholic Fatty Liver Disease in Rats.
khadr, A., Kamel, M., Abbas, N., Ebeid, M., Darwish, W. (2019). MicroRNA-33a and MiR-34a as a Molecular Targets for Pomegranate Peel Extract During Treatment of Non-Alcoholic Fatty Liver Disease in Rats.. EKB Journal Management System, 5(1), 67-79. doi: 10.21608/rjab.2019.76806
Abada E. khadr; Maher A. Kamel; Nasser H. Abbas; Mohamed E. Ebeid; Weal S. Darwish. "MicroRNA-33a and MiR-34a as a Molecular Targets for Pomegranate Peel Extract During Treatment of Non-Alcoholic Fatty Liver Disease in Rats.". EKB Journal Management System, 5, 1, 2019, 67-79. doi: 10.21608/rjab.2019.76806
khadr, A., Kamel, M., Abbas, N., Ebeid, M., Darwish, W. (2019). 'MicroRNA-33a and MiR-34a as a Molecular Targets for Pomegranate Peel Extract During Treatment of Non-Alcoholic Fatty Liver Disease in Rats.', EKB Journal Management System, 5(1), pp. 67-79. doi: 10.21608/rjab.2019.76806
khadr, A., Kamel, M., Abbas, N., Ebeid, M., Darwish, W. MicroRNA-33a and MiR-34a as a Molecular Targets for Pomegranate Peel Extract During Treatment of Non-Alcoholic Fatty Liver Disease in Rats.. EKB Journal Management System, 2019; 5(1): 67-79. doi: 10.21608/rjab.2019.76806

MicroRNA-33a and MiR-34a as a Molecular Targets for Pomegranate Peel Extract During Treatment of Non-Alcoholic Fatty Liver Disease in Rats.

Research Journal of Applied Biotechnology
Article 7, Volume 5, Issue 1, June 2019, Page 67-79  XML PDF (1.15 MB)
Document Type: Original Article
DOI: 10.21608/rjab.2019.76806
View on SCiNiTO View on SCiNiTO
Authors
Abada E. khadr* 1; Maher A. Kamel2; Nasser H. Abbas3; Mohamed E. Ebeid3; Weal S. Darwish3
1Molecular Biology and Biochemistry department, Genetic Engineering and Biotechnology Research Institute (GEBRI), University of Sadat City, Egypt
2Medical Research Institute, University of Alexandria, Egypt
3Molecular Biology and Biochemistry department, Genetic Engineering and Biotechnology Research Institute (GEBRI), University of Sadat City, Egypt.
Abstract
Non-alcoholic fatty liver disease (NAFLD), hepatic manifestation of metabolic syndrome, has been considered the most common liver disease nowadays. The aim of this study is to evaluate the potential therapeutic effect of pomegranate peel extract on the experimental rat model of non-alcoholic fatty liver diseases (NAFLD) and to explore the role of mir-33a and mir-34a as the molecular targets for these therapeutic effects.Fifty male albino Wistarrats were used in the present study. The NAFLD was induces in rats using high fat diet (HFD). The pomegranate peel extract (PPE) was used in different doses (50,100 and 150) for 30 days.The present study documents the ameliorating effects of PPE on hyperglycemia, insulin resistance, lipid profile and liver functions in NAFL rats in a dose-dependent manner compared to untreated rats.The ameliorating effects on the metabolic parameter are associated with significant correction in the hepatic expression of MiR-33a and MiR-34ain a dose-dependent manner. From the present study we can concluded that the PPE have efficient anti-steatotic effect which may be mediated through modulation of MiR-33a and MiR-34.
Keywords
NAFL; MiR-33a; MiR-34a; PPE
Statistics
Article View: 333
PDF Download: 415